Correction: Vescalagin and castalagin reduce the toxicity of amyloid-beta42 oligomers through the remodelling of its secondary structure

Ana R Araújo; Sergio Camero; Pablo Taboada; Rui L Reis; Ricardo A Pires

doi:10.1039/d1cc90090k

Correction: Vescalagin and castalagin reduce the toxicity of amyloid-beta42 oligomers through the remodelling of its secondary structure

Chem Commun (Camb). 2021 Mar 28;57(25):3158. doi: 10.1039/d1cc90090k. Epub 2021 Mar 17.

Authors

Ana R Araújo¹, Sergio Camero, Pablo Taboada, Rui L Reis, Ricardo A Pires

Affiliation

¹ 3B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal. rpires@i3bs.uminho.pt.

PMID: 33729246
DOI: 10.1039/d1cc90090k

Abstract

Correction for 'Vescalagin and castalagin reduce the toxicity of amyloid-beta42 oligomers through the remodelling of its secondary structure' by Ana R. Araújo et al., Chem. Commun., 2020, 56, 3187-3190, DOI: .

Publication types

Published Erratum